Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $69,762 | 27 | 58.7% |
| Honoraria | $13,940 | 4 | 11.7% |
| Travel and Lodging | $13,604 | 22 | 11.4% |
| Unspecified | $12,542 | 5 | 10.5% |
| Food and Beverage | $7,948 | 137 | 6.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,088 | 2 | 0.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $51,043 | 97 | $0 (2024) |
| Amgen Inc. | $28,687 | 20 | $0 (2024) |
| Horizon Therapeutics plc | $10,765 | 10 | $0 (2023) |
| Vertex Pharmaceuticals Incorporated | $8,367 | 2 | $0 (2022) |
| NESTLE HEALTHCARE NUTRITION INC. | $7,450 | 2 | $0 (2023) |
| Organon LLC | $4,590 | 2 | $0 (2023) |
| Wilson Cook Medical Incorporated | $2,590 | 6 | $0 (2019) |
| Boston Scientific Corporation | $1,641 | 23 | $0 (2024) |
| Medtronic, Inc. | $653.76 | 8 | $0 (2024) |
| Cook Medical LLC | $496.73 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,347 | 37 | Amgen Inc. ($28,687) |
| 2023 | $20,163 | 32 | Horizon Therapeutics plc ($10,765) |
| 2022 | $10,114 | 34 | Vertex Pharmaceuticals Incorporated ($7,875) |
| 2021 | $10,211 | 16 | AbbVie Inc. ($4,892) |
| 2020 | $13,057 | 9 | AbbVie Inc. ($12,962) |
| 2019 | $10,975 | 35 | AbbVie, Inc. ($7,914) |
| 2018 | $6,549 | 15 | AbbVie, Inc. ($5,654) |
| 2017 | $18,468 | 19 | AbbVie, Inc. ($17,847) |
All Payment Transactions
197 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ERBE USA INC | vio 3 (Device) | Food and Beverage | Cash or cash equivalent | $75.00 | General |
| Category: Gastroenterology | ||||||
| 12/13/2024 | Olympus America Inc. | VISIGLIDE (Device) | Food and Beverage | In-kind items and services | $65.60 | General |
| Category: Endotherapy | ||||||
| 11/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/19/2024 | Boston Scientific Corporation | EMBOLD Fibered (Device) | Food and Beverage | In-kind items and services | $51.21 | General |
| Category: Embold_PI | ||||||
| 10/18/2024 | Amgen Inc. | UPLIZNA (Biological) | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/15/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $4.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/14/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | In-kind items and services | $8,583.28 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/14/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $971.29 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/14/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | In-kind items and services | $689.95 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/14/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $86.24 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/14/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | In-kind items and services | $78.15 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/14/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | In-kind items and services | $72.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/14/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/27/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/17/2024 | 3-D Matrix, Inc. | — | Food and Beverage | In-kind items and services | $143.23 | General |
| 08/13/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| 08/13/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $775.00 | General |
| 08/13/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | Cash or cash equivalent | $130.75 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/13/2024 | Amgen Inc. | — | Food and Beverage | Cash or cash equivalent | $85.42 | General |
| 08/06/2024 | Amgen Inc. | UPLIZNA (Biological) | Consulting Fee | Cash or cash equivalent | $4,312.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $33.35 | General |
| 07/02/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/06/2024 | Amgen Inc. | UPLIZNA (Biological) | Consulting Fee | Cash or cash equivalent | $1,349.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/05/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 243 | 264 | $258,099 | $41,310 |
| 2022 | 14 | 366 | 403 | $375,119 | $68,814 |
| 2021 | 15 | 333 | 368 | $325,591 | $66,332 |
| 2020 | 9 | 208 | 243 | $202,117 | $43,078 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 43 | 46 | $52,302 | $9,024 | 17.3% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 18 | 27 | $34,535 | $8,111 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 54 | $22,382 | $7,763 | 34.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 21 | 21 | $30,786 | $4,235 | 13.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $10,503 | $3,075 | 29.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 36 | 36 | $31,464 | $2,323 | 7.4% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $11,817 | $2,249 | 19.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $22,760 | $2,134 | 9.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $11,310 | $1,357 | 12.0% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 13 | 14 | $30,240 | $1,040 | 3.4% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 33 | 42 | $39,690 | $14,664 | 36.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 56 | 79 | $30,731 | $12,020 | 39.1% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 41 | 41 | $46,617 | $7,730 | 16.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 29 | 29 | $16,124 | $5,451 | 33.8% |
| 43276 | Replacement of stent in pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 11 | 13 | $12,740 | $4,849 | 38.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 22 | 22 | $32,252 | $4,581 | 14.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 49 | 49 | $42,826 | $3,675 | 8.6% |
| 43275 | Removal of stent from pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 14 | 14 | $10,920 | $3,345 | 30.6% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2022 | 23 | 25 | $54,000 | $3,234 | 6.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $28,450 | $2,798 | 9.8% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $17,271 | $2,748 | 15.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $14,490 | $1,981 | 13.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $9,802 | $907.56 | 9.3% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope | Facility | 2022 | 17 | 18 | $19,206 | $830.63 | 4.3% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope via mouth | Facility | 2021 | 37 | 51 | $48,195 | $17,956 | 37.3% |
About Vikesh Singh, M.D., M.S
Vikesh Singh, M.D., M.S is a Internal Medicine healthcare provider based in Lutherville Timonium, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083649081.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Vikesh Singh, M.D., M.S has received a total of $118,884 in payments from pharmaceutical and medical device companies, with $29,347 received in 2024. These payments were reported across 197 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($69,762).
As a Medicare-enrolled provider, Singh has provided services to 1,150 Medicare beneficiaries, totaling 1,278 services with total Medicare billing of $219,534. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Lutherville Timonium, MD
- Active Since 07/11/2006
- Last Updated 02/19/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083649081
Products in Payments
- Creon (Drug) $31,267
- UPLIZNA (Biological) $26,094
- CREON (Drug) $18,439
- UPLIZNA (Drug) $10,765
- ZENPEP (Drug) $3,850
- Cook Medical Sphincterotomy (Device) $2,401
- GI GENIUS (Device) $302.65
- OverStitch Endoscopic Suturing System (Device) $272.07
- General - Therapies (Device) $259.74
- LINZESS (Drug) $224.36
- COOK MEDICAL ENDOSCOPIC ULTRASOUND (Device) $222.23
- Cook Medical Biliary (Device) $219.10
- AXIOS (Device) $185.96
- FUJIFILM (Device) $182.37
- ENDOFLIP (Device) $170.66
- Axios (Device) $170.05
- GI Genius (Device) $164.94
- Single Use Electrosurgical Knife KD-655 (Device) $147.14
- GENERAL BILIARY DEVICES (Device) $131.63
- FUSION QUATTRO (Device) $127.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.